ProCE Banner Activity

Using New Treatment Options for Patients With Advances Urothelial Cancer

Clinical Thought

Expert nurse practitioners discuss evidence-based recommendations for how best to incorporate new therapeutic options for patients with advanced urothelial cancer.

Released: May 31, 2022

Expiration: May 30, 2023

No longer available for credit.



Mary Weinstein Dunn

Mary Weinstein Dunn, MSN

Nurse Practitioner
Department of Urology and Medicine, Division of Oncology
University of North Carolina Chapel Hill
Chapel Hill, North Carolina

Cristina Salabao

Cristina Salabao, MSN, FNP-C, AOCNP

Nurse Practitioner
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts


This activity is supported by an educational grant from Astellas & Seagen Inc.


Seagen and Astellas

Target Audience

NPs and PAs in oncology


Cristina Salabao, MSN, FNP-C, AOCNP, has no relevant financial relationships to disclose.

Mary Weinstein Dunn, MSN, NP-C, OCN, RN, has no relevant financial relationships to disclose.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.


Clinical Thought

Additional Information

Program Medium

This program has been made available online.